![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
Jacqueline Barrientos, MD
Hodgkin’s Lymphoma Specialist
Specialities: Chronic Lymphocytic Leukemia, Hodgkin Lymphoma, Non-Hodgkin Lymphoma
Spoken languages: English
Clinical Expertise
- Chronic Lymphocytic Leukemia
- Non-Hodgkin’s Lymphoma
- Hodgkin’s Lymphoma
About
Dr. Jacqueline C. Barrientos is a hematologist-oncologist at Mount Sinai Medical Center where she has been appointed Chief of Hematologic Malignancies and Director of Oncology Research. She is Adjunct Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in New York.
Dr. Barrientos received her medical degree from the Ponce Health Sciences University where she was the recipient of two Howard Hughes Medical Institute Fellowship Awards for research and was elected to the Alpha Omega Alpha National Medical Honor Society. She completed her internship and residency in internal medicine at the Yale-New Haven Hospital of the Yale School of Medicine, and her fellowship in Hematology/Oncology at NY Presbyterian Hospital/Weill Cornell Medical Center in New York City, where she also served as Chief Fellow. She obtained a Master’s degree in Clinical Investigation at the Weill Cornell Graduate School of Medical Sciences. She is board certified in hematology and medical oncology.
Dr. Barrientos served as Principal Investigator on several clinical trials that lead to the approval of novel therapies that changed the treatment paradigm of CLL and lymphoma. She has co-authored several landmark publications in prestigious medical journals. She has been honored with several awards including the American Society of Hematology AMFDP Award. In her role as an educator, she works with major national societies to advance the medical knowledge of patients and colleagues.
Location
Mount Sinai Medical Center: 4306 Alton Rd 3rd Floor, Miami Beach, FL 33140, USA
Get the latest thought leadership on your Angioimmunoblastic T-Cell Lymphoma delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.
HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.
Copyright © 2024 HealthTree Foundation. All rights reserved.
Tax ID 45-5354811